Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01222832 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

A Phase 2 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.

Completed
Registry status
Phase 2
Development phase
226
Enrollment target

NCT01222832: Completed Phase 2 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.

NCT01222832 is a Phase 2 study that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 226 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01222832, a Phase 2 study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.

COMPLETED
Registry status
Phase 2
Development phase
226 participants
Enrollment target

Study Summary

This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.

Primary Outcome

Number of participants without infections on post-op visits 90 days.

Interventions

  • DRUG Bacitracin

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2010-07
Est. Completion 2012-06
Phase Phase 2

What the finished NCT01222832 record still lists

NCT01222832 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% higher).

The record links to 0 conditions, and to 1 intervention - of which Bacitracin is the first listed.

NCT01222832 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01222832 about?

NCT01222832 is a clinical study titled "Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge". This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.

What is the current status of trial NCT01222832?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 226 participants. The study started on 2010-07. Estimated completion is 2012-06.

What interventions are being tested in trial NCT01222832?

The interventions under investigation include: Bacitracin (DRUG).

Who is sponsoring clinical trial NCT01222832?

This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01222832's enrollment target sits among peer trials

226 267th of 2000 higher than 1,734 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01222832, the US trial registry maintained by the National Library of Medicine. NCT01222832 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.